T-Hydrocan™ Update 12-30-2013 from Berkeley Bio. Hi
T-Hydrocan™ Update 12-30-2013 from Berkeley Bio. Hi Everyone, As we anxiously await the bottles and labels for the first Dharmanol™ product, we have been beta-testing the new T-Hydrocan™ tablets that will follow closely on its heels. T-Hydrocan tablets contain active THC (fully decarboxylated), an array of organic terpenes and terpenoids that are found in the cannabis plant, and a mixture of the minor cannabinoids.
We have been getting asked about the difference between the T-Hydrocan tablets, and the YAK Cannabis Extract capsules that the Dharma Care and Hospice Program has been providing to patients for the last six years.
The YAK capsules are truly whole-plant. Organically grown cannabis flowers are pulverized and extracted in butter. After extraction, the powdered cannabis flowers are not removed, resulting in a true “whole-plant” product.
T-Hydrocan tablets come in two forms: T-Hydrocan™ Whole Plant and T-Hydrocan™ RMC (Refined Mixed Cannabinoids).
1. The T-Hydrocan™ Whole Plant tablets are made with an extract of cannabis flowers that is made with organically-certified ethanol (drinking alcohol) which enables the capture of all of the alcohol soluble elements of the plant. Separated terpenes and terpenoids, which are insoluble in alcohol but can be removed with steam distillation, are added to the mixture, along with organic cold-pressed hemp oil, and ascorbic acid (vitamin C) as a preservative.
2. T-Hydrocan RMC (Refined Mixed Cannabinoids) tablets contain a highly purified extract of cannabis flowers, in the form of a translucent red or gold-colored oil which contains about 70% to 75% cannabinoids.
Several variations of the basic T-Hydrocan tablets will follow in the first part of 2014. These specialty supplements will enhance the basic formula with substantial doses of various cannabis terpenes and terpenoids which have, in themselves, shown considerable medicinal efficacy.
T-Hydrocan™ Citrolene™ will be the first, containing d-limonene, a terpene which has been shown to bind with the same receptors as synthetic drugs such as Valium and Xanax, producing a pronounced relaxing and anti-spasmodic effect.
The flowers used for production are known to be pesticide and chemical free, and purity and potency is determined by testing at every step of the process by CW Analytical Labs in Oakland. The starting material is also tested for microbiological contamination, as are all of the finished products.
We would like to thank all those who have helped us in the beta-testing of the new tablets and wish all who have followed our progress a very Happy New Year.
Dave
SK3 Group Inc. (SKTO) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...
Continue Reading
Boardwalk's Leadership Shift: Enter Scott Wexler Nothing spices up a pipeline company's menu like a fresh plate of leadership. Boardwalk Pipelines, out in Houston, just handed the keys to their finance dungeon over to Scott Wexler. He's stepping in as the chief financial officer and senior VP of corporate strategic development, an upgrade that got announced today. Packing...
Continue Reading
Taking Tax Deadlines Head-On Tax season's got businesses sweating all over the country, but it doesn't have to be a full-scale panic attack if you've got the right gear. That's where ezAccounting steps in, dishing out a reliable solution to hit those looming IRS Form 941 deadlines without a migraine. By November 2, 2026, companies are looking to dodge the bullet of...
Continue Reading
Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...
Continue Reading
Investing in the Future of Lung Cancer Research Damn, you don't see this kind of commitment every day! LUNGevity Foundation is dropping over a million bucks on the table to swell the ranks of lung cancer researchers. They're not just tossing dollars at established players; they're betting on fresh minds to shake things up in this critical field. Tackling lung cancer isn't...
Continue Reading
Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...
Continue Reading
Natural Gas Abundance Meets Conversion Hurdles It’s a wild scene when you've got oodles of natural gas but struggle to get it into AI data centers. That’s the picture today: U.S. gas production hitting a high of 137 billion cubic feet daily, while converting that gas into practical energy is the real challenge. You see, the gas market is ready to rumble, ticking...
Continue Reading
Aktia's Ratings Get a Boost In the world of financial minutiae, it was S&P Global Ratings that took the stage, buzzing about Aktia Bank Plc. The bank just had its ratings held steady with an outlook lift from negative to stable. That's like someone throwing you a life jacket when you're treading water; significant if you're trying to stay afloat, not so much if you've got...
Continue Reading
The Fed Sits Tight, But CD Rates Surge Isn't it a kicker when the Fed holds rates steady, yet the CD market is buzzing like a crowded trading floor on a bull run? We've seen the Federal Reserve hold its ground without budging interest rates, keeping everyone guessing while inflation's still a shadow in the corner. But the star of the show here isn't the Fed's poker...
Continue Reading
Revolutionizing Risk Management with KPI Swaps Boy, if there's one thing that gets my ticker going, it's the buzz of innovation in financial markets. Rothera just landed a CFTC stamp of approval for something that's about to shake up how institutional traders manage risk: Key Performance Indicator (KPI) swaps. And can you believe it? This isn't just another derivative...
Continue Reading
Top 5 Most Recently Viewed Articles
Market Overview: U.S. Stock Dynamics U.S. stocks saw a positive trend with the Dow Jones index experiencing a significant rise of over 250 points in recent trading sessions. Index Performance On this day, the Dow Jones Industrial Average rose by 0.63%, concluding at 42,177.28. Similarly, the NASDAQ increased by 0.54% to reach 18,179.88, while the S&P 500 also saw gains of...
Continue Reading
Understanding the Concept of Technology for Good Amidst the fast-evolving landscape of artificial intelligence (AI), one individual stands out for their insights into how technology can profoundly benefit humanity. As a member of the UN advisory body on AI, Zhang Linghan, a seasoned professor, presents a comprehensive view on the philosophy of 'technology for good...
Continue Reading
Navigating the Future for Women in the Workplace In a rapidly changing world, the dynamics of the workplace continue to evolve, especially for women. The latest insights underline significant potential setbacks in corporate America that could undermine the progress achieved in recent years. Organizations that once championed diversity and inclusion are at a crossroads,...
Continue Reading
Barington Capital Urges Matthews International Shareholders to Act Barington Capital Group, L.P., an activist investment firm, is taking the initiative to address the governance concerns at Matthews International Corporation. The firm, owning about 2.2% of Matthews' common stock, has sent a compelling message to shareholders, urging them to elect their director nominees...
Continue Reading
Overview of the Annual General Meeting Proposals Sampo plc has provided essential insights into the proposals for their upcoming Annual General Meeting (AGM), reflecting the company's strategic initiatives for the upcoming financial year. These proposals stem from the Board of Directors and the Audit Committee, aiming to enhance operational efficiency and shareholder...
Continue Reading